2. ā¢ Pancytopenia is defined as decrease in all three hematologic
cell lines.
ā¢ The condition is not a disease in itself but a common pathway
caused by various etiologies .
3. It is characterized (for Adults) by
ā¢ Hemoglobin < 12 g/dL in women and
13 g/dL in men,
ā¢ Platelets < 150,000 / Ī¼L,
ā¢ Leukocytes < 4 x 103/ Ī¼L or (Absolute neutrophil count < 1.8x
103/Ī¼L.)
4. It is characterized (for children) by
ā¢ Hemoglobin < 10 g/dL
ā¢ Platelets < 100,000 / Ī¼L,
ā¢ Leukocytes < 4 x 103/ Ī¼L or (Absolute neutrophil
count < 1.5x 103/Ī¼L.)
5. Reticulocyte production index (RPI)=
Patientās hematocrit X retic count %
Normal hematocrit reticulocyte mat. Time
RPI is a good indicator of adequacy of the bone marrow response.
If RPI >2 ļ good bone marrow response
RPI < 2 ļ inadequate compensatory bone marrow response
10. Epidemiology
ā¢ Depending upon the cause , the disease presents in a varied
age group.
ā¢ Several studies in India by Chandra et al , Gayathri et al etc
showed megaloblastic anemia as the most frequent cause
followed by aplastic anemia.
12. FANCONI ANEMIA
ā¢ Multigenic, autosomal recessive disorder
ā¢ Common hereditary marrow failure disease , associated
with chromosomal breaks.
13. ā¢ Mutations result in defects in hematopoietic stem cells, and
the cells are ineffective in DNA repair (chromosomal
breakage disorder).
ā¢ Premalignant disorder ā the long-term risk of progression to
MDS and AML.
16. Hematologic findings
ā¢ Presents with cytopenias or pancytopenia
ā¢ Anemia is normocytic normochromic.
ā¢ Bone marrow is hypocellular with increased fat and
infiltration by lymphocytes and plasma cells.
ā¢ Erythroblasts are seen in the same stage of maturation.
ā¢ HbF is increased and i antigen expression on the red cells.
ā¢ Chromosomal breakage is demonstrable with DEB
(diepoxybutane) and Mitomycin C.
17.
18. DYSKERATOSIS CONGENITA
ā¢ X-linked recessive/autosomal dominant/autosomal recessive
disorder.
ā¢ Mutations in DKC1 at Xq28, a gene that encodes for dyskerin.
ā¢ Mutations in band 3q26 in TERC, a part of telomerase
complex
ā¢ Children with dyskeratosis congenita and telomeropathies in
adults - mutations in genes of telomerase complex / shelterin
complex.
19. ā¢ Cell lines affected Myeloid mainly, but
Erythroid & Megakaryocytic also affected.
ā¢ Monocytopenia is common Blood finding
22. Two congenital clinical types are encountered.
ā¢ THROMBOCYTOPENIA WITH ABSENT RADII (TAR)
ā¢ CONGENITAL THROMBOCYTOPENIA WITH
MEGAKARYOCYTIC HYPOPLASIA
23. GATA2 DISORDERS
ā¢ Autosomal dominant disorders with marrow failure,
MDS or AML.
ā¢ Heterozygous mutation in the GATA2 genes
ā¢ Bone marrow is hypocellular with multilineage
dysplasia, especially of megakaryocytes.
ā¢ Increase reticulin fibrosis occurs in marrow.
ā¢ Increased susceptibility to non tuberculous mycobacteria
and viral infections
ā¢ Monocytopenia, B and NK cell lymphocytopenia are lab
findings.
32. Degree of Severity of Aplastic Anemia
Severe aplastic anemia
bone marrow with < 30% cellularity
and presence of ā„ 2 of the following:
ā¢ Absolute neutrophil count < 500/uL (< 0.5 Ć 10^9/L)
ā¢ Transfusion dependance with ,ARC < 60,000/uL (< 60 Ć
10^9/L)
ā¢ Platelet count < 20,000/uL (< 20 Ć 10^9/L)
Very severe aplastic anemia
Which fulfill the criteria of severe AA with an absolute
neutrophil count < 200/uL (< 0.2 x10^9/L).
33. Case 2
ā¢ 67 year/male previously well
ā¢ CBC normal last year
ā¢ presented with lethargy and gum bleeding since three weeks
ā¢ Hemoglobin 6,
ā¢ TLC 3000
ā¢ platelet 17000
ā¢ Examination
ā¢ well built ,pale looking ,no fever
ā¢ no significant drug history, no lymph node palpable
ā¢ no organomegaly
ā¢ iron ,vitamin b12, folate ā all within normal range
ā¢ viral screening- all negative
34. ā¢ Peripheral blood film -Pancytopenia
ā¢ ARC reduced
ā¢ Bone marrow - hypocellular marrow
NORMAL BONE MARROW HYPOPLASTIC BONE MARROW
35. Hypocellular bone marrow ā aplastic anaemia
ā¢ Hypocellular MDS/AML /T LGL/ partiality treated ALL
ā¢ Viral infections parvovirus b19 ,hepatitis ,HIV
ā¢ Drug induced bone marrow - antineoplastic agents
,sulphonamides
ā¢ Auto immune diseases -SLE/RA
ā¢ Aplastic crisis in hemolytic anaemia transfusion associated
GVHD
ā¢ Inherited bone marrow failure syndrome eg.Fanconi anemia
36. Case 3
ā¢ 45 year/ male comes with a history of generalized weakness ,tingling
sensation
ā¢ numbness of hands and feet since 35 days with tinge of yellowish discoloration
ā¢ loss of appetite and significant weight loss with history of loose motions since
30 days
ā¢ hemoglobin 8g/dl
ā¢ TLC 1900 /cumm
ā¢ Neutrophil 74
ā¢ lymphocyte 29
ā¢ Eosinophils 4
ā¢ monocyte 3
ā¢ platelets 63000
ā¢ MCV 119fl
ā¢ MCH 28pg RDW 26.2
40. MEGALOBLASTIC ANEMIA
ā¢ Megaloblastic anemias are a group of disorders in which
the rate of DNA synthesis is retarded
ā¢ RNA synthesis is impaired to a lesser extent, resulting in
imbalanced cell growth.
ā¢ Cell populations undergoing rapid proliferation like the
hematopoietic cells manifest the alterations in cell size and
maturation.
41. ā¢ Symptoms of lethargy, Weakness, Glossitis, and
Neurological disturbances occur in cobalamin
deficiency.
42. ā¢ Bone marrow is markedly hypercellular with erythroid
hyperplasia
ā¢ The hallmark in the marrow is the nuclear-cytoplasmic
maturation dissociation, which is best seen in the erythroid
precursors .
ā¢ Megaloblasts have open sieve like nuclear chromatin
43.
44. Case 4
39 year old lady with history of generalized weakness , fever since
15 days
ā¢ bleeding from gums and nose ,ecchymotic patches since 3 days
ā¢ hemoglobin 7.3 g%
ā¢ total leukocyte count 1100 /cumm
ā¢ neutrophils 00 %
ā¢ lymphocyte 30%
ā¢ blasts 2%
ā¢ promyelocytes 68 %
ā¢ platelets 40000
ā¢ PT 64 seconds (control 12 sec )
ā¢ aPTT 98 seconds (control 30 sec)
45. ā¢ Fibrinogen 40 mg/dl
ā¢ Bleeding is out of proportion to thrombocytopenia
ā¢ Circulating promyelocytes without any mature neutrophils
49. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
ā¢ Life-threatening disorder, presented as pancytopenia.
ā¢ It can be either familial or sporadic, caused by various triggers
like infections, malignancies, rheumatologic and
immunodeficiency syndromes.
ā¢ It represents a severe hyperinflammatory condition with the cardinal
symptoms of prolonged fever ,cytopenia's ,
hepatosplenomegaly and hemophagocytosis by activated
macrophages.
50. ā¢ Initial evaluation should include complete blood count with
differential, coagulation studies, fibrinogen, serum ferritin
(usually>1000 mg/mL), liver function tests and triglycerides.
ā¢ Biopsies often reveal red cell ingestion by histiocytes
(hemophagocytosis)
ā¢ Treatment is corticosteroids, cyclosporin A, immunoglobulins ,
Etoposide.
51. Case 6
ā¢ 70 year old male with history of symptomatic anemia requiring
repeated blood transfusions since 3 months , pallor + , otherwise
unremarkable
ā¢ hemoglobin 5
ā¢ TLC 2700
ā¢ neutrophils 60
ā¢ lymphocytes 36
ā¢ Eosinophils 1
ā¢ monocytes 3
ā¢ Platelets 89000 MCV 127 fl MCH 28 pg, RDW 21.4
ā¢ retic count 1.5%
ā¢ bone marrow shows hypercellular bone marrow with trilineage
dysplasia with blasts
53. Myelodysplastic syndrome
ā¢ Myelodysplastic syndrome is a clonal stem cell disorder
characterized by dysplastic bone marrow.
ā¢ It usually affects elderly with a male predominance
ā¢ Peripheral blood findings are pancytopenia, bicytopenia, or
isolated cytopenias with reticulocytopenia.
ā¢ A macrocytic anemia is common, hypogranulated
neutrophils also seen in the smear.
ā¢ Morphologic evidence of dysplasia in the peripheral smear.
54. ā¢ Bone marrow aspirate shows normocellular or
hypercellular with various degrees of qualitative
abnormalities of one or more cell lineages.
ā¢ Flow cytometry and immunophenotyping helps in
differentiating MDS from other cytopenias in post cancer
therapy patients.
55.
56.
57. Case 7
ā¢ 75 year/male chronic alcoholic, fever, septic looking, acute
kidney injury ,pancytopenia
ā¢ hemoglobin 9 ,TLC 4 ,platelet 20000
ā¢ blood cultures taken
ā¢ started antibiotics
58. ā¢ peripheral blood smear -Anaemia ,thrombocytopenia ,shift to
lift ,leukoerythroblastic picture
ā¢ Neutrophils with toxic granulations and vaculations presence
of inclusion bodies ? bacilli within
neutrophil cytoplasm
ā¢ blood culture - listeria monocytogenes
64. Case 9
ā¢ 45 year / female presented with fatigue, abdominal
discomfort ,massive splenomegaly
ā¢ Pancytopenic picture
65. ā¢ Myelofibrosis
ā¢ no clinically relevant mutations were detected in JAK2, CALR
and MPL genes on this patient
ā¢ serum SSA /RO antibodies = 81.07 ( < 20)
66. Other causes of Myelofibrosis
ā¢ Primary autoimmune Myelofibrosis
ā¢ disseminated tuberculosis or histoplasmosis
ā¢ metastatic carcinoma (esp breast, prostate etc)
ā¢ other Myeloproliferative neoplasm in fibrotic phase
ā¢ Hairy cell leukemia
ā¢ renal osteodystrophy
ā¢ SLE/ scleroderma
ā¢ radiation exposure
ā¢ osteoporosis
ā¢ mastocytosis
67. PRIMARY MYELOFIBROSIS
ā¢ Primary myelofibrosis is one of the chronic
myeloproliferative neoplasms (MPN)
ā¢ Characterized by clonal proliferation of abnormal
megakaryocytes.
ā¢ Usually present with pancytopenia, extreme fatigue and an
enlarged spleen and liver .
ā¢ The peripheral smear shows leukoerythroblastic reaction
(myelophthisic smear), tear drop cells, left-shifted
(immature) white blood cells and nucleated RBCs
68. ā¢ Circulating CD34+ cells can help in distinguishing
this entity from other forms of myeloproliferative
disorders.
ā¢ Bone marrow aspiration usually is difficult, yielding
a dry tap, and bone marrow biopsy is necessary for
demonstrating reticulin fibrosis.
69. Case 10
ā¢ 55 year/ male alcoholic , anxiety disorder, no comorbidities
ā¢ fatigue since 3 months
ā¢ hemoglobin 8
ā¢ TLC 6500
ā¢ platelets 130000
ā¢ PS -marocytic RBCs
ā¢ LDH , b12 - normal
ā¢ bone marrow shows dysplasia in all three lineages
70. ā¢ Diagnosed as MDS
ā¢ tranfused 3 PRBCs , as routine- given B12 and folic acid
ā¢ asked to follow up with cytogenetics and biopsy report
71. ā¢ 15 days later
ā¢ appetite greatly improved
ā¢ general condition improved
ā¢ hemoglobin 10
ā¢ TLC 8500
ā¢ platelets 180000
72. Dysplastic changes in bone marrow
ā¢ megaloblastic anaemia
ā¢ heavy metal toxicity
ā¢ alcohol abuse
ā¢ HIV , parvovirus
ā¢ anti-tubercular therapy
ā¢ drugs- chemotherapy , valproate
ā¢ chronic liver disease
ā¢ if all the above our ruled out- myelodysplastic syndrome
73. Case 11
ā¢ 45 year /male
ā¢ in ICU ,alcoholic
ā¢ pneumonia with sepsis
ā¢ pancytopenia -worsening rapidly
74. ā¢ Bone marrow aspiration- dilute
ā¢ Bone marrow biopsy shows necrosis
77. Storage disorders
ā¢ Gaucher disease - inherited lysosomal storage disease -
autosomal recessive defect of the gene encoding Ī²-
glucocerebrosidase,
ā¢ The lipid-laden cells are called Gaucher cells and are
predominantly found in the spleen, liver, bone marrow
and rarely lung.
ā¢ Clinical presentation- hepatosplenomegaly, pancytopenia,
bone complications
78.
79. HYPERSPLENISM
ā¢ Hypersplenism is characterized by anemia , leukopenia
and/or thrombocytopenia.
ā¢ It causes pancytopenia by splenic sequestration
ā¢ Causes - Cirrhosis, congestive heart failure, malignancies
like leukemia/lymphoma and infections like TB, typhoid
fever , malaria , leishmaniasis etc
ā¢ Patients can present with pain or fullness in the left upper
quadrant, abdominal distension or referred pain to the
shoulder.
80. Paroxysmal nocturnal
hemoglobinuria
ā¢ PNH is an acquired mutation in the PIGA gene ( X Linked
chromosome) resulting in defective cell membrane leading
to hemolysis, pancytopenia and thrombosis.
ā¢ Defect in glycosylphosphatidylinositol (GPI linked proteins )
ā CD 55 and CD 59 (membrane associated complement
regulatory proteins.)
81. ā¢ Anemia symptoms ā jaundice , morning cola colored urine
Hematologic findings-normocytic normochromic, increased reticulocyte
count.
ā¢ Cases with marrow failure, display leucopenia, thrombocytopenia and low
reticulocyte counts.
82. ā¢ Bone marrow- cellular, erythroid hyperplasia. In later stages aplasia
supervenes and may be difficult to differentiate fromAplastic Anemia.
ā¢ Iron stores are usually nil in PNH, while they are increased in AA.
ā¢ Diagnosis- Flow cytometry detects CD16/CD66b in granulocytes &
CD55,CD59 in RBCs.
ā¢ Flow cytometric analysis (FLAER) of granulocytes and red cells for CD56
and CD59 is useful in distinguishing AA from PNH overlap syndrome.
83. ā¢ Large granular Lymphocyte (LGL) leukemia is a clonal disorder
affecting the large granular lymphocytes which can cause marrow
infiltration leading to cytopenia.
ā¢ The diagnosis is based on immunophenotypic analysis of the
peripheral smear but bone marrow biopsy/aspirate may be
required in some cases
ā¢ HCL typically presents with massive splenomegaly and
pancytopenia.
ā¢ Granulomatous diseases like miliary TB and sarcoidosis and
metabolic disorders like Gaucher disease can also cause
pancytopenia by causing intense marrow infiltration.
84. Pancytopenia may present with the following emergencies
ā¢ Febrile Neutropenia
ā¢ Metabolic emergencies (e.g., symptomatic hyperkalemia,
hypercalcemia, tumor lysis syndrome)
ā¢ Disseminated intravascular coagulation
ā¢ Hemophagocytic lymphohistiocytosis
ā¢ Abnormal peripheral blood smear (e.g., microangiopathy, blasts)
ā¢ Severe aplastic anemia
ā¢ Symptomatic anemia (e.g., cardiac ischemia, hemodynamic
instability, worsening congestive heart failure)
ā¢ Thrombocytopenia (platelets <10,000/microL, or <50,000/microL
associated with bleeding)
85. when to say pancytopenia urgent?
ā¢ Absolute neutrophil count <1000/ ul with fever or other
evidence of infection
ā¢ or <500/ul
ā¢ symptomatic anemia
ā¢ thrombocytopenia
ā¢ platelets < 10,000 /uL or platelets < 50,000 / uL with clinical
significant bleeding
When is a referral less urgent?
ā¢ Asymptomatic
ā¢ Blood counts stable
87. History Taking
ā¢ Severity and durations of symptoms
ā¢ Constitutional symptoms - fever , night sweats , weight loss , fatigue
ā¢ Age
ā¢ Mucosal Bleeding
ā¢ Jaundice
ā¢ Joint pain
ā¢ Diet history
ā¢ Infections
ā¢ Previous treatment history
ā¢ Drug history
ā¢ Alcohol consumption history
ā¢ Family history
89. ā CBC with Peripheral smear and Reticulocyte count
ā Vitamin B12 and folate assays
ā LFT
ā Serum iron profile
ā Serology ā HIV, HBsAg and HCV
90. What to look in the Peripheral Blood Smear?
ā¢ Red Cells ā Macrocytes, Ovalocytes, Tear drop forms,
Nucleated RBCs
ā Inclusions ā Cabot rings, basophilic stippling, siderocytes
ā¢ WBC ā Hypersegmented neutrophils, Hyposegmented-
hypogranular neutrophils, hairy cells, Large granular
lymphocytes, Abnormal promyelocytes, Blasts, Shift to left
ā¢ Platelets ā Giant or small sized
ā¢ Hemoparasites
91.
92. ā¢ Further Work-up
ā¢ Bone marrow Morphology
ā¢ Serological testing for viruses, auto-immune disorders
ā¢ Cultures
ā Ancillary testing
ā¢ Flow cytometry / Immunophenotyping
93. Bone Marrow Evaluation
ā¢ Not required ā if Vitamin B12 or folate
assays are low, consistent with
Megaloblastosis
ā¢ Yes for all Pancytopenias
ā When levels of Vitamin B12 and / or folate assays
cannot explain the degree of severity of
Pancytopenia
97. Summary
ā¢ Pancytopenia is a decrease in all three blood cell lines with a
wide list of possible causes.
ā¢ Most common causes include megaloblastic anemia, aplastic
anemia myelodysplastic syndrome and acute leukemia
ā¢ Hypersplenism ,infections and drugs .
ā¢ Urgency of evaluation depends primarily on the severity and
duration of symptoms.
ā¢ Management focuses primarily on stabilizing clinical status
followed by thorough investigation to identify the cause.
98. Reference
ā¢ Singh T. Atlas and Text of Hematology: 4th edition. New
Delhi: Avichal Publication Company; 2018
ā¢ Mckenzie SB, Williams JL. Clinical Laboratory
Hematology: 4th edition. Boston: Pearson; 2016
ā¢ Greer PJ et al. Wintrobeās Clinical Hematology: 14th
edition. Philadelphia: Wolters Kluwer; 2019
ā¢ Kumar V, Abbas AK, Aster JC. Robbins & Cotran
Pathologic Basis of Disease. 10th ed. Vol I. New York:
Elsevier; 2021.